A few years ago, GW Pharmaceuticals aimed to have the first Food and Drug Administration (FDA) approved cannabis-based medicine to treat people with rare types of epilepsy. After years of clinical trials, they realized this goal in the summer of 2018 when the FDA approved Epidiolex, their CBD-based medicine. They now hope to go through … Continue reading GW Pharmaceuticals is Looking to Treat Autism with Cannabis